University of Virginia
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Study Examining Stress During Pregnancy
- Conditions
- Stress
- Interventions
- Behavioral: Relaxation Training
- First Posted Date
- 2006-03-27
- Last Posted Date
- 2009-12-30
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 40
- Registration Number
- NCT00307320
- Locations
- 🇺🇸
University of Virginia, Department of Psychology, Charlottesville, Virginia, United States
Impact of Heart Rate Characteristics Monitoring in Neonates
- Conditions
- Sepsis
- Interventions
- Device: HeRO heart rate characteristics monitor
- First Posted Date
- 2006-03-27
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 3003
- Registration Number
- NCT00307333
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Winnie Plamer Hospital for Women and Babies, Orlando, Florida, United States
Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Biological: synthetic breast cancer peptides-tetanus toxoid-Montanide ISA-51 vaccine
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2013-04-09
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 12
- Registration Number
- NCT00304096
- Locations
- 🇺🇸
University of Virginia Cancer Center, Charlottesville, Virginia, United States
Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals
- First Posted Date
- 2006-03-09
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 5
- Registration Number
- NCT00300742
- Locations
- 🇺🇸
UVA CARE, Charlottesville, Virginia, United States
🇺🇸UVA CARE Richmond, Richmond, Virginia, United States
Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
- Conditions
- Cancer of the Cervix
- First Posted Date
- 2006-02-16
- Last Posted Date
- 2011-05-30
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 30
- Registration Number
- NCT00292955
- Locations
- 🇺🇸
Washinton University School of Medicine, St. Louis, Missouri, United States
🇺🇸University of Virginia Cancer Center, Charlottesville, Virginia, United States
Glucose Regulation in Acute Stroke Patients (GRASP) Study
- Conditions
- StrokeHyperglycemia
- Interventions
- Drug: IV glucose insulin and potassium, GIKOther: standard care
- First Posted Date
- 2006-01-27
- Last Posted Date
- 2009-08-21
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 74
- Registration Number
- NCT00282867
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇺🇸Medical College of Georgia, Augusta, Georgia, United States
Cost Effectiveness and Efficacy of Kyphoplasty and Vertebroplasty Trial
- Conditions
- Osteoporotic Vertebral Compression Fractures
- Interventions
- Procedure: Kyphoplasty
- First Posted Date
- 2006-01-20
- Last Posted Date
- 2016-08-18
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 112
- Registration Number
- NCT00279877
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2013-12-10
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 42
- Registration Number
- NCT00278122
- Locations
- 🇺🇸
University of Virginia Cancer Center, Charlottesville, Virginia, United States
Comparison of Two Different Diets on Health Outcomes
- Conditions
- Metabolic Syndrome X
- First Posted Date
- 2005-12-23
- Last Posted Date
- 2009-02-18
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 24
- Registration Number
- NCT00269646
- Locations
- 🇺🇸
University of Virginia General Clinical Research Center, Charlottesville, Virginia, United States
Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2005-12-15
- Last Posted Date
- 2008-01-28
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 46
- Registration Number
- NCT00265928
- Locations
- 🇺🇸
University of Virginia Cancer Center at UV Health System, Charlottesville, Virginia, United States